Abeer M Shaaban Selected Research

Estrogen Receptors

11/2014	Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series.
6/2010	Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer.
8/2008	Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients.
8/2005	A multi-centre investigation towards reaching a consensus on the immunohistochemical detection of ERbeta in archival formalin-fixed paraffin embedded human breast tissue.
12/2003	Declining estrogen receptor-beta expression defines malignant progression of human breast neoplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Abeer M Shaaban Research Topics

Disease

37	Breast Neoplasms (Breast Cancer) 04/2024 - 02/2002
22	Neoplasms (Cancer) 04/2024 - 12/2003
7	Male Breast Neoplasms (Male Breast Cancer) 01/2022 - 06/2012
6	Carcinoma (Carcinomatosis) 08/2023 - 01/2018
4	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2022 - 12/2003
3	Carcinogenesis 08/2010 - 12/2003
3	Hyperplasia 12/2005 - 02/2002
2	Rare Diseases (Rare Disease) 08/2017 - 11/2014
2	Ductal Carcinoma 07/2016 - 06/2010
2	Residual Neoplasm 01/2016 - 09/2015
1	Monosomy 10/2022
1	Papillary Carcinoma 01/2022
1	Margins of Excision 01/2021
1	Inflammation (Inflammations) 01/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Calciphylaxis 01/2020
1	Obesity 10/2016
1	Cicatrix (Scar) 12/2013
1	Polyps 08/2013
1	Neoplasm Metastasis (Metastasis) 08/2008
1	Endometriosis 02/2004
1	Adenocarcinoma 02/2004
1	Metaplasia 02/2004

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2010
9	Hormones (Hormone)IBA 01/2022 - 02/2002
6	Estrogen Receptor alphaIBA 10/2011 - 02/2002
6	Estrogen Receptor betaIBA 09/2010 - 12/2003
5	Estrogen ReceptorsIBA 11/2014 - 12/2003
5	Protein Isoforms (Isoforms)IBA 06/2012 - 08/2008
4	human ERBB2 proteinIBA 04/2023 - 09/2015
4	Tamoxifen FDA LinkGeneric 01/2020 - 01/2008
4	Progesterone Receptors (Progesterone Receptor)IBA 09/2015 - 08/2008
4	Proteins (Proteins, Gene)FDA Link 06/2011 - 12/2003
3	Phenobarbital (Luminal)FDA Link 08/2023 - 06/2012
3	Indicators and Reagents (Reagents)IBA 01/2015 - 08/2008
3	Androgen Receptors (Androgen Receptor)IBA 11/2014 - 08/2008
2	Messenger RNA (mRNA)IBA 04/2024 - 06/2010
2	Trastuzumab (Herceptin)FDA Link 04/2024 - 01/2022
2	Keratins (Keratin)IBA 01/2022 - 01/2018
2	Monoclonal AntibodiesIBA 02/2004 - 12/2003
1	Progesterone FDA LinkGeneric 04/2024
1	neratinibIBA 04/2024
1	LigandsIBA 04/2024
1	Colloids (Colloid)IBA 08/2023
1	trastuzumab deruxtecanIBA 08/2023
1	TetraspaninsIBA 01/2023
1	OxysterolsIBA 01/2023
1	ElementsIBA 10/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 10/2022
1	cyclo(Arg-Pro) (CI 4)IBA 02/2022
1	Lapatinib (GW572016)FDA Link 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Dinoprostone (PGE2)FDA Link 01/2020
1	15-hydroxyprostaglandin dehydrogenaseIBA 01/2020
1	CalciumIBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	teleocalcinIBA 10/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Small Untranslated RNAIBA 01/2018
1	Histones (Histone)IBA 12/2017
1	Eukaryotic Initiation Factor-4EIBA 05/2017
1	Everolimus FDA Link 05/2017
1	Cyproterone AcetateIBA 11/2014
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2014
1	Androgen Antagonists (Antiandrogens)IBA 11/2014
1	3-N-(2-fluoroethyl)spiperone (FESP)IBA 08/2013
1	Serine (L-Serine)FDA Link 09/2010
1	RNA (Ribonucleic Acid)IBA 08/2010
1	5' Untranslated Regions (5' UTR)IBA 08/2010
1	AntibodiesIBA 08/2008
1	Cell Adhesion MoleculesIBA 01/2008
1	Carcinoembryonic AntigenIBA 01/2008
1	ParaffinIBA 02/2004
1	AntigensIBA 02/2004
1	CyclinsIBA 02/2004
1	Cyclin EIBA 02/2004
1	Cyclin BIBA 02/2004
1	Cyclin AIBA 02/2004

Therapy/Procedure

13	Therapeutics 08/2023 - 02/2002
11	Neoadjuvant Therapy 01/2023 - 09/2015
3	Mastectomy (Mammectomy) 10/2022 - 12/2013
2	Radiotherapy 01/2021 - 01/2020
2	Lasers (Laser) 01/2020 - 01/2009
2	Drug Therapy (Chemotherapy) 01/2020 - 09/2015
1	Immunotherapy 01/2023
1	Segmental Mastectomy (Lumpectomy) 01/2021
1	Renal Dialysis (Hemodialysis) 01/2020